Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,388,976
-$104,756 QoQ
Shares Held
358,270
-19.0% QoQ
Ownership
0.510%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 124 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. PHVS ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in PHVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,388,976 | 358,270 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,493,732 | 442,256 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,129,538 | 941,605 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,379,359 | 816,808 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,504,744 | 767,315 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,201,565 | 586,087 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,509,486 | 443,896 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,028,037 | 325,488 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,003,094 | 585,271 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,515,415 | 757,915 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $23,637,678 | 842,698 | Shares | Sole | 2024-02-16 | |
| No filing history on record for this holder in this stock. | ||||||